Cytokinetics (CYTK) Tops Q4 EPS by 8c
Tweet
Share
E-mailGet Alerts CYTK Hot Sheet
Price: $74.13 +0.93%
Financial Fact:
Research and development revenues from related parties: 5.57M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Research and development revenues from related parties: 5.57M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Cytokinetics (NASDAQ: CYTK) reported Q4 EPS of ($0.24), $0.08 better than the analyst estimate of ($0.32). Revenue for the quarter came in at $9.8 million versus the consensus estimate of $10.49 million.
For earnings history and earnings-related data on Cytokinetics (CYTK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
- H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
